Compile Data Set for Download or QSAR
maximum 50k data
Found 176 with Last Name = 'sakata' and Initial = 'y'
TargetBeta-galactosidase(Bos taurus (Bovine))
Keio University

Curated by ChEMBL
LigandPNGBDBM50133507(4-Decylamino-6-methyl-cyclohexane-1,2,3-triol | CH...)
Affinity DataKi:  9nMAssay Description:Inhibitory activity of the compound against beta-galactosidase in bovine liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118923((1S,2S,3R)-4-Methyl-6-octylamino-cyclohexane-1,2,3...)
Affinity DataKi:  16nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50065258((2S,3R,4S,5R)-2-Methyl-piperidine-3,4,5-triol | (2...)
Affinity DataKi:  31nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118928((1S,2S,3R)-4-Methyl-6-phenethylamino-cyclohexane-1...)
Affinity DataKi:  32nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactosidase(Bos taurus (Bovine))
Keio University

Curated by ChEMBL
LigandPNGBDBM50133504(4-Methyl-6-(4-phenyl-butylamino)-cyclohexane-1,2,3...)
Affinity DataKi:  46nMAssay Description:Inhibitory activity of the compound against beta-galactosidase in bovine liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118921((1R,2S,3S)-4-Heptylamino-6-methyl-cyclohexane-1,2,...)
Affinity DataKi:  48nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118920((1R,2S,3S)-4-Benzylamino-6-methyl-cyclohexane-1,2,...)
Affinity DataKi:  69nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118922((1R,2S,3S)-4-Butylamino-6-methyl-cyclohexane-1,2,3...)
Affinity DataKi:  74nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118919((1S,2S,3R)-4-Methyl-6-nonylamino-cyclohexane-1,2,3...)
Affinity DataKi:  110nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactosidase(Bos taurus (Bovine))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118923((1S,2S,3R)-4-Methyl-6-octylamino-cyclohexane-1,2,3...)
Affinity DataKi:  110nMAssay Description:Inhibitory activity of the compound against beta-galactosidase in bovine liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50118926((1R,2S,3S)-4-Ethylamino-6-methyl-cyclohexane-1,2,3...)
Affinity DataKi:  180nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50403994(CHEMBL2114287)
Affinity DataKi:  1.00E+3nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue alpha-L-fucosidase(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50403995(CHEMBL2115269)
Affinity DataKi:  2.90E+3nMAssay Description:Binding affinity against alpha-L-fucosidase in bovine kidney was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111656(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.230nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110571(CHEMBL167991 | FR-230481 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  0.540nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111644(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.590nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111645(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.590nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111645(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.700nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110562(5-Chloro-3-(2-{4-[(3-methoxy-6,7,8,9-tetrahydro-5H...)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111646(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.710nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111647(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.850nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111641(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.890nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110567(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111650(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111650(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.20nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110569(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111649(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111654(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111641(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111651(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111647(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.5nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111643(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111644(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111642(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111654(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111642(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.60nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111649(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.60nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111648(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.80nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111643(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.90nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111657(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  3.30nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110565(CHEMBL164873 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  3.70nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111655(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  3.80nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111652(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.40nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111655(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111651(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111653(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  6.10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111653(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  9nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111648(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110573(3-Chloro-N-[2-(4-{[(1-hydroxy-7-methoxy-1,2,3,4-te...)
Affinity DataIC50:  11nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110572(CHEMBL167860 | N-[2-(4-{[(1-Hydroxy-7-methoxy-1,2,...)
Affinity DataIC50:  13nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 176 total ) | Next | Last >>
Jump to: